For many Gabonese, malaria remains a constant struggle. Libreville resident Julicia Nfono says the disease keeps coming back despite preventive measures.
Breakdown
- Doctors in Gabon are testing a single-dose malaria treatment to address growing resistance to existing drugs.
- The new treatment, led by Dr. Ghislain Mambunguma, combines four widely available anti-malaria compounds in a one-time dose. 8s
- The single-dose cleared malaria parasites in 93 percent of patients, matching the effectiveness of the standard three-day regimen. 39s
- Malaria remains a major public health problem in Gabon, with over 154,000 cases and high incidence among children under five according to 2024 data. 1m 36s
- The single-dose approach could improve treatment compliance, reduce resistance, and make malaria care more accessible in Africa's most affected communities. 1m 57s